23/09/2009 (Agence Europe) - In our article on new antibiotics in yesterday's newsletter (N° 9982), in Paragraph 3, Professor Cars was referring to Europe as a whole being late. We would clarify, too, that the pharmaceutical industry had been developing new molecules specifically for older people and which present fewer risks.